4.7 Article

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease

Journal

ANNALS OF NEUROLOGY
Volume 72, Issue 6, Pages 893-901

Publisher

WILEY
DOI: 10.1002/ana.23687

Keywords

-

Funding

  1. Parkinson's UK Innovation Grant
  2. National Institute of Health Research Academic Clinical Fellowship
  3. Teva Lundbeck
  4. Merck-Serono
  5. Biogen-Idec
  6. Ironwood
  7. Genentech
  8. Teva
  9. GSK
  10. Sanofi-Aventis
  11. Novartis
  12. Roche
  13. UCB Pharmaceuticals
  14. Vertex
  15. Eisai
  16. Elan
  17. Fiveprime
  18. Bayer-Schering
  19. Synthon BV
  20. Genyme
  21. GW Pharma
  22. Merz
  23. PSP Association
  24. Weston Trust-Reta Lila Howard Foundation
  25. Meda
  26. Boehringer Ingelheim
  27. Ipsen
  28. Lundbeck
  29. Allergan
  30. Orion
  31. BIAL
  32. Noscira
  33. Solvay
  34. Neurosearch
  35. Osmotica Pharmaceuticals
  36. National Institute for Health Research [ACF-2009-18-017] Funding Source: researchfish
  37. Parkinson's UK [K-1006, F-1201] Funding Source: researchfish

Ask authors/readers for more resources

Objective: To evaluate the association between diagnosis of Parkinson disease (PD) and risk factors or early symptoms amenable to population-based screening. Methods: A systematic review and meta-analysis of risk factors for PD. Results: The strongest associations with later diagnosis of PD were found for having a first-degree or any relative with PD (odds ratio [OR], 3.23; 95% confidence interval [CI], 2.65-3.93 and OR, 4.45; 95% CI, 3.39-5.83) or any relative with tremor (OR, 2.74; 95% CI, 2.10-3.57), constipation (relative risk [RR], 2.34; 95% CI, 1.55-3.53), or lack of smoking history (current vs never: RR, 0.44; 95% CI, 0.39-0.50), each at least doubling the risk of PD. Further positive significant associations were found for history of anxiety or depression, pesticide exposure, head injury, rural living, beta-blockers, farming occupation, and well-water drinking, and negative significant associations were found for coffee drinking, hypertension, nonsteroidal anti-inflammatory drugs, calcium channel blockers, and alcohol, but not for diabetes mellitus, cancer, oral contraceptive pill use, surgical menopause, hormone replacement therapy, statins, acetaminophen/paracetamol, aspirin, tea drinking, history of general anesthesia, or gastric ulcers. In the systematic review, additional associations included negative associations with raised serum urate, and single studies or studies with conflicting results. Interpretation: The strongest risk factors associated with later PD diagnosis are having a family history of PD or tremor, a history of constipation, and lack of smoking history. Further factors also but less strongly contribute to risk of PD diagnosis or, as some premotor symptoms, require further standardized studies to demonstrate the magnitude of risk associated with them. ANN NEUROL 2012;72:893-901

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available